36 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18746567 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | LOVE, TREVOR M | 1611 | Final Rejection | Jun 18, 2024 |
| 18413822 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | TRAN, SUSAN T | 1615 | Final Rejection | Jan 16, 2024 |
| 18544532 | SOLID DISPERSION OF A HER2 INHIBITOR | LIU, SUE XU | 1616 | Non-Final OA | Dec 19, 2023 |
| 18530255 | SOLID FORMS OF A SGC ACTIVATOR | HAVLIN, ROBERT H | 1626 | Non-Final OA | Dec 06, 2023 |
| 18520650 | ANTI-TRKB ANTIBODIES | BORGEEST, CHRISTINA M | 1675 | Non-Final OA | Nov 28, 2023 |
| 18515654 | VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD | MIKNIS, ZACHARY J | 1658 | Final Rejection | Nov 21, 2023 |
| 18508346 | BINDING MOLECULES FOR THE TREATMENT OF CANCER | KAUFMAN, CLAIRE M | 1674 | Non-Final OA | Nov 14, 2023 |
| 18493142 | HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING | GAUGER, PAUL RANDALL | 1629 | Non-Final OA | Oct 24, 2023 |
| 18493126 | HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING | BARSKY, JARED | 1628 | Non-Final OA | Oct 24, 2023 |
| 18551553 | Pharmaceutical Combinations for Treating Cancer | DRISCOLL, MAUREEN VARINA | 1644 | Non-Final OA | Sep 20, 2023 |
| 18468885 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Sep 18, 2023 |
| 18281047 | CHIRAL SYNTHONS FOR THE SYNTHESIS OF CHIRAL PHOSPHOROTHIOATES | OTTON, ALICIA L | 1699 | Final Rejection | Sep 08, 2023 |
| 18461850 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Sep 06, 2023 |
| 18459590 | ANTIBODY MOLECULES FOR CANCER TREATMENT | CHANDRA, GYAN | 1674 | Non-Final OA | Sep 01, 2023 |
| 18234400 | PHARMACEUTICAL FORMULATIONS OF NINTEDANIB FOR INTRAOCULAR USE | HUANG, GIGI GEORGIANA | 1613 | Non-Final OA | Aug 16, 2023 |
| 18362034 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | MOTEVALLI, OROD | 1628 | Non-Final OA | Jul 31, 2023 |
| 18353133 | ANTI-IL-36R ANTIBODY FORMULATIONS | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | Jul 17, 2023 |
| 18221936 | Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists | MOORE, SUSANNA | 1624 | Final Rejection | Jul 14, 2023 |
| 18351515 | BINDING MOLECULES FOR THE TREATMENT OF CANCER | DUNN, LINDSAY MICHELLE | 1644 | Non-Final OA | Jul 13, 2023 |
| 18337693 | MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT | GODDARD, LAURA B | 1642 | Final Rejection | Jun 20, 2023 |
| 18298882 | COMBINATION TREATMENT | SHIBUYA, MARK LANCE | 1631 | Non-Final OA | Apr 11, 2023 |
| 18185493 | ANG2-BINDING MOLECULES | MOSELEY II, NELSON B | 1642 | Non-Final OA | Mar 17, 2023 |
| 18019771 | DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES | HABTE, KAHSAY | 1624 | Non-Final OA | Feb 03, 2023 |
| 18145234 | MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN | ANGELL, JON E | 1637 | Non-Final OA | Dec 22, 2022 |
| 18057421 | CELL CULTURE MEDIUM | JOHNSON, KARA D | 1632 | Final Rejection | Nov 21, 2022 |
| 17999122 | VIRAL VECTORS AND NUCLEIC ACIDS FOR REGULATED GENE THERAPY | SHIN, DANA H | 1635 | Non-Final OA | Nov 17, 2022 |
| 17914773 | INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONS | RZECZYCKI, PHILLIP MATTHEW | 1625 | Non-Final OA | Sep 27, 2022 |
| 17914373 | USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS | BOESEN, CHRISTIAN C | 1684 | Non-Final OA | Sep 26, 2022 |
| 17904487 | MAMMALIAN CELL CULTURE PROCESSES | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Aug 18, 2022 |
| 17763723 | CONCENTRATED PERFUSION MEDIUM | MOSS, NATALIE M | 1653 | Final Rejection | Mar 25, 2022 |
| 17686880 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | TIEN, LUCY MINYU | 1612 | Non-Final OA | Mar 04, 2022 |
| 17530559 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | KASSA, TIGABU | 1619 | Non-Final OA | Nov 19, 2021 |
| 17525433 | CELL ENGINEERING USING RNAs | HOLLAND, PAUL J | 1656 | Non-Final OA | Nov 12, 2021 |
| 17608328 | VIRAL VECTORS AND NUCLEIC ACIDS FOR USE IN THE TREATMENT OF PF-ILD AND IPF | ZAHORIK, AMANDA MARY | 1636 | Non-Final OA | Nov 02, 2021 |
| 17414970 | BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE | KAUFMAN, CLAIRE M | 1674 | Non-Final OA | Jun 17, 2021 |
| 17212456 | IL-11 ANTIBODIES | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Mar 25, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial